Drug Type Stem cell therapy |
Synonyms HPDSC(New York Medical College) |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Acute Lymphoblastic Leukemia | Phase 1 | United States | 01 Apr 2013 | |
| Acute Myeloid Leukemia | Phase 1 | United States | 01 Apr 2013 | |
| Adrenoleukodystrophy | Phase 1 | United States | 01 Apr 2013 | |
| Amegakaryocytic thrombocytopenia | Phase 1 | United States | 01 Apr 2013 | |
| Anemia, Diamond-Blackfan | Phase 1 | United States | 01 Apr 2013 | |
| Fucosidosis | Phase 1 | United States | 01 Apr 2013 | |
| Gaucher Disease | Phase 1 | United States | 01 Apr 2013 | |
| Leukodystrophy, Globoid Cell | Phase 1 | United States | 01 Apr 2013 | |
| Leukodystrophy, Metachromatic | Phase 1 | United States | 01 Apr 2013 | |
| Mucopolysaccharidosis I | Phase 1 | United States | 01 Apr 2013 |





